Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0098 | 0.5466 | 0.5278 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3308 | 0.3308 |
Loa Loa (eye worm) | acetyltransferase | 0.0169 | 1 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Echinococcus granulosus | TRP transient receptor potential channel | 0.0037 | 0.1535 | 0.1583 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0037 | 0.1566 | 0.1615 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.005 | 0.2366 | 0.244 |
Echinococcus multilocularis | GPCR, family 2 | 0.0031 | 0.1173 | 0.1173 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.0397 | 0.0772 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1325 | 0.0966 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0397 | 0.0397 |
Schistosoma mansoni | DNA polymerase eta | 0.0019 | 0.0397 | 0.0397 |
Loa Loa (eye worm) | RNA binding protein | 0.0065 | 0.3308 | 0.3032 |
Schistosoma mansoni | transient receptor potential channel 4 | 0.0099 | 0.5502 | 0.5502 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3308 | 0.3308 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0065 | 0.3364 | 0.3364 |
Echinococcus granulosus | transient receptor potential ion channel A | 0.0096 | 0.5292 | 0.5457 |
Brugia malayi | MH2 domain containing protein | 0.0117 | 0.6653 | 0.6653 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.0397 | 0.2586 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.0397 | 0.0409 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Schistosoma mansoni | hypothetical protein | 0.0067 | 0.3479 | 0.3479 |
Echinococcus granulosus | GPCR family 2 | 0.0031 | 0.1173 | 0.121 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.1173 | 0.0808 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0037 | 0.1534 | 0.2985 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.0397 | 0.2586 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0046 | 0.2101 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.1173 | 0.1173 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0065 | 0.3308 | 0.3308 |
Echinococcus granulosus | transient receptor potential gamma protein | 0.0099 | 0.5502 | 0.5674 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0084 | 0.4542 | 0.8837 |
Loa Loa (eye worm) | glutathione reductase | 0.0037 | 0.1534 | 0.1184 |
Echinococcus multilocularis | dna polymerase eta | 0.0019 | 0.0397 | 0.0397 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0084 | 0.4542 | 0.8837 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0084 | 0.4542 | 0.8837 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.005 | 0.2366 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.3153 | 0.287 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0021 | 0.0138 |
Plasmodium falciparum | glutathione reductase | 0.0037 | 0.1534 | 0.7301 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0117 | 0.6653 | 0.6515 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0031 | 0.1173 | 0.1173 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0098 | 0.5466 | 0.5466 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.0397 | 0.0397 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0013 | 0 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3308 | 0.3308 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0397 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0065 | 0.3308 | 0.3308 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0093 | 0.514 | 1 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.0397 | 0.0397 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0169 | 1 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0397 | 0.0409 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0093 | 0.514 | 1 |
Brugia malayi | TAR-binding protein | 0.0065 | 0.3308 | 0.3308 |
Leishmania major | DNA polymerase eta, putative | 0.0019 | 0.0397 | 0.2586 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.3479 | 0.3209 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Echinococcus granulosus | dna polymerase eta | 0.0019 | 0.0397 | 0.0409 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0397 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1535 | 0.1186 |
Brugia malayi | glutathione reductase | 0.0037 | 0.1534 | 0.1534 |
Trypanosoma brucei | trypanothione reductase | 0.0037 | 0.1534 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.0397 | 0.1677 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.0397 | 0.2586 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0013 | 0 | 0.5 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0084 | 0.4542 | 0.8837 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.1173 | 0.1173 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0037 | 0.1566 | 0.1566 |
Schistosoma mansoni | transient receptor potential channel | 0.0065 | 0.3364 | 0.3364 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0397 | 0.1888 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0397 | 0.2586 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0098 | 0.5466 | 0.5278 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.0397 | 0.0397 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0031 | 0.1173 | 0.0808 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0093 | 0.514 | 1 |
Schistosoma mansoni | transient receptor potential channel | 0.0099 | 0.5502 | 0.5502 |
Plasmodium vivax | glutathione reductase, putative | 0.0037 | 0.1534 | 0.6484 |
Brugia malayi | Transient-receptor-potential like protein | 0.0037 | 0.1535 | 0.1535 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0046 | 0.2101 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3308 | 0.3308 |
Mycobacterium tuberculosis | Probable reductase | 0.0084 | 0.4542 | 0.8837 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0084 | 0.4542 | 0.8837 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0065 | 0.3308 | 0.3032 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.005 | 0.2366 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0021 | 0.0138 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0098 | 0.5466 | 0.5466 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Treponema pallidum | NADH oxidase | 0.0013 | 0 | 0.5 |
Echinococcus multilocularis | TRP (transient receptor potential) channel | 0.0037 | 0.1535 | 0.1535 |
Echinococcus granulosus | tar DNA binding protein | 0.0065 | 0.3308 | 0.3412 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0037 | 0.1534 | 0.1184 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.1173 | 0.1173 |
Echinococcus multilocularis | transient receptor potential ion channel A | 0.0096 | 0.5292 | 0.5292 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0117 | 0.6653 | 0.6515 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0093 | 0.514 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.005 | 0.2366 | 1 |
Brugia malayi | RNA binding protein | 0.0065 | 0.3308 | 0.3308 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0031 | 0.1173 | 0.1173 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0169 | 1 | 1 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0046 | 0.2101 | 1 |
Schistosoma mansoni | transient receptor potential channel | 0.0065 | 0.3364 | 0.3364 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0397 | 0.2586 |
Plasmodium falciparum | thioredoxin reductase | 0.0037 | 0.1534 | 0.7301 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.0397 | 0.1677 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3308 | 0.3308 |
Trypanosoma brucei | unspecified product | 0.0013 | 0.0021 | 0.0138 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.005 | 0.2366 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.005 | 0.2366 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0397 | 0.2586 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0031 | 0.1173 | 0.1173 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.0397 | 0.2586 |
Brugia malayi | Thioredoxin reductase | 0.0037 | 0.1534 | 0.1534 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0013 | 0 | 0.5 |
Trypanosoma brucei | unspecified product | 0.0013 | 0.0021 | 0.0138 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0397 | 0.0397 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0031 | 0.1173 | 0.121 |
Leishmania major | trypanothione reductase | 0.0037 | 0.1534 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0065 | 0.3364 | 0.3469 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0067 | 0.3479 | 0.3479 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0397 | 0.0397 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.5502 | 0.5316 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0031 | 0.1173 | 0.1173 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0021 | 0.0138 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0037 | 0.1534 | 0.6484 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0065 | 0.3364 | 0.3469 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.0397 | 0.0772 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0065 | 0.3364 | 0.3364 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0037 | 0.1534 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0031 | 0.1173 | 0.121 |
Toxoplasma gondii | thioredoxin reductase | 0.0037 | 0.1534 | 0.6484 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0397 | 0.2586 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.1173 | 0.1173 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0165 | 0.9697 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0065 | 0.3308 | 0.3032 |
Echinococcus multilocularis | transient receptor potential gamma protein | 0.0099 | 0.5502 | 0.5502 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.